Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Cardinal Health ( (CAH) ) is now available.
Cardinal Health reported a 4% drop in first-quarter revenue to $52.3 billion, yet saw a 12% rise in non-GAAP operating earnings to $625 million, driven by strong growth in its Pharmaceutical and Specialty Solutions segment. Despite the decrease in overall revenue, excluding a significant contract expiration, earnings were buoyed by increased sales in specialty pharmaceuticals and a successful COVID-19 vaccine distribution earlier in the season. This performance led to an upward revision of the fiscal 2025 EPS guidance, reflecting the company’s confidence in its strategic execution and value creation for shareholders.
For detailed information about CAH stock, go to TipRanks’ Stock Analysis page.